Snow avalanche deaths in Switzerland from 1995 to 2014-Results of a nation-wide linkage study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 18 06 2019
accepted: 11 11 2019
entrez: 4 12 2019
pubmed: 4 12 2019
medline: 26 3 2020
Statut: epublish

Résumé

More than 20 people die each year in snow avalanches in Switzerland. Previous studies have primarily described these victims, but were not population based. We investigated sociodemographic factors for avalanche mortality between 1995 and 2014 in the entire Swiss resident population. Within the Swiss National Cohort we ascertained avalanche deaths by anonymous data linkage with the avalanche accident database at the Swiss WSL Institute of Snow and Avalanche Research SLF. We calculated incidence rates, by dividing the number of deaths from avalanches by the number of person-years, and hazard ratios (HRs) for sociodemographic and economic characteristics using Cox proportional hazard models. The data linkage yielded 250 deaths from avalanche within the SNC population for the 20 years 1995 to 2014. The median distance between the place of residence and the place of the event (avalanche) was 61.1 km. Male gender, younger age (15-45 years), Swiss nationality, living in the Alpine regions, higher education, living in the highest socioeconomic quintile of neighbourhoods, being single, and living in a household with one or more children were associated with higher avalanche mortality rates. Furthermore, for younger persons (<40 years) the hazard of dying in an avalanche between 2005 and 2014 was significantly lower than in the years 1995 to 2004 (HR = 0.56, 95%-CI: 0.36-0.85). Over a 20-year period in Switzerland, higher rates of dying in an avalanche were observed in men, in younger age groups, and persons with tertiary education, living in the highest socioeconomic quintile of neighbourhoods, and living in an Alpine region. For younger persons (<40 years), the hazard declined during the study period.

Identifiants

pubmed: 31794568
doi: 10.1371/journal.pone.0225735
pii: PONE-D-19-17260
pmc: PMC6890213
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0225735

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Wilderness Environ Med. 2016 Mar;27(1):46-52
pubmed: 26948553
Int J Public Health. 2010 Aug;55(4):239-42
pubmed: 20556473
Wilderness Environ Med. 2015 Sep;26(3):417-21
pubmed: 25937551
Resuscitation. 2007 Dec;75(3):476-83
pubmed: 17689170
Wilderness Environ Med. 2016 Jun;27(2):282-6
pubmed: 27116920
BMC Med Inform Decis Mak. 2013 Jan 04;13:1
pubmed: 23289362
Scand J Med Sci Sports. 2014 Oct;24(5):823-9
pubmed: 23815413
Int J Epidemiol. 2009 Apr;38(2):379-84
pubmed: 18326512
J Epidemiol Community Health. 2012 Dec;66(12):1129-36
pubmed: 22717282
Prev Sci. 2012 Dec;13(6):562-73
pubmed: 22961005
Antimicrob Agents Chemother. 2004 Aug;48(8):2787-92
pubmed: 15273082
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131

Auteurs

Claudia Berlin (C)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Frank Techel (F)

WSL Institute for Snow and Avalanche Research SLF, Davos, Switzerland.
University of Zürich, Department of Geography, Zürich, Switzerland.

Beat Kaspar Moor (BK)

Department of Orthopaedic Surgery and Traumatology, Hôpital du Valais, Martigny, Switzerland.

Marcel Zwahlen (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Rebecca Maria Hasler (RM)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Department of Emergency Medicine, Inselspital, University Hospital Bern, Bern, Switzerland.
Department of Trauma, University Hospital Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH